| Literature DB >> 1670796 |
Abstract
The standard design for randomised clinical trials may be inappropriate when the clinician believes that one of the treatments being tested is superior for the patient, or when the clinician has a preference for one of the treatments. For such instances the suggestion is that the patient is randomly allocated to treatment only when there is clinical disagreement about treatment of choice for that patient, and then the patient is assigned to a clinician who had thought that the regimen allocated is the one most appropriate for that patient.Entities:
Mesh:
Year: 1991 PMID: 1670796 DOI: 10.1016/0140-6736(91)90809-4
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321